No conflicts of interest were declared.
Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity†
Article first published online: 26 SEP 2011
Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
The Journal of Pathology
Volume 226, Issue 1, pages 108–119, January 2012
How to Cite
Giricz, O., Reynolds, P. A., Ramnauth, A., Liu, C., Wang, T., Stead, L., Childs, G., Rohan, T., Shapiro, N., Fineberg, S., Kenny, P. A. and Loudig, O. (2012), Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity. J. Pathol., 226: 108–119. doi: 10.1002/path.2978
- Issue published online: 1 DEC 2011
- Article first published online: 26 SEP 2011
- Accepted manuscript online: 3 AUG 2011 03:05AM EST
- Manuscript Accepted: 23 JUL 2011
- Manuscript Revised: 4 JUL 2011
- Manuscript Received: 13 APR 2011
|path_2978_sm_supportinginformations.doc||21K||Supporting Information: Legends to Figure S1|
|path_2978_sm_supportinginformations.tif||11486K||Supporting Information: Figure S1. In situ hybridization analysis of hsa-miR-182 expression during lobular neoplastic progression.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.